Skip to main content
Journal cover image

ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials.

Publication ,  Journal Article
Barsevick, AM; Cleeland, CS; Manning, DC; O'Mara, AM; Reeve, BB; Scott, JA; Sloan, JA ...
Published in: J Pain Symptom Manage
June 2010

CONTEXT: Development of pharmacological and behavioral interventions for cancer-related fatigue (CRF) requires adequate measures of this symptom. A guidance document from the Food and Drug Administration offers criteria for the formulation and evaluation of patient-reported outcome measures used in clinical trials to support drug or device labeling claims. METHODS: An independent working group, ASCPRO (Assessing Symptoms of Cancer Using Patient-Reported Outcomes), has begun developing recommendations for the measurement of symptoms in oncology clinical trials. The recommendations of the Fatigue Task Force for measurement of CRF are presented here. RESULTS: There was consensus that CRF could be measured effectively in clinical trials as the sensation of fatigue or tiredness, impact of fatigue/tiredness on usual functioning, or as both sensation and impact. The ASCPRO Fatigue Task Force constructed a definition and conceptual model to guide the measurement of CRF. ASCPRO recommendations do not endorse a specific fatigue measure but clarify how to evaluate and implement fatigue assessments in clinical studies. The selection of a CRF measure should be tailored to the goals of the research. Measurement issues related to various research environments were also discussed. CONCLUSIONS: There exist in the literature good measures of CRF for clinical trials, with strong evidence of clarity and comprehensibility to patients, content and construct validity, reliability, and sensitivity to change in conditions in which one would expect them to change (assay sensitivity), and sufficient evidence to establish guides for interpreting changes in scores. Direction for future research is discussed.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Pain Symptom Manage

DOI

EISSN

1873-6513

Publication Date

June 2010

Volume

39

Issue

6

Start / End Page

1086 / 1099

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Treatment Outcome
  • Terminology as Topic
  • Patients
  • Neoplasms
  • Humans
  • Fatigue
  • Clinical Trials as Topic
  • Anesthesiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Barsevick, A. M., Cleeland, C. S., Manning, D. C., O’Mara, A. M., Reeve, B. B., Scott, J. A., … ASCPRO (Assessing Symptoms of Cancer Using Patient-Reported Outcomes), . (2010). ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage, 39(6), 1086–1099. https://doi.org/10.1016/j.jpainsymman.2010.02.006
Barsevick, Andrea M., Charles S. Cleeland, Donald C. Manning, Ann M. O’Mara, Bryce B. Reeve, Jane A. Scott, Jeff A. Sloan, and Jeff A. ASCPRO (Assessing Symptoms of Cancer Using Patient-Reported Outcomes). “ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials.J Pain Symptom Manage 39, no. 6 (June 2010): 1086–99. https://doi.org/10.1016/j.jpainsymman.2010.02.006.
Barsevick AM, Cleeland CS, Manning DC, O’Mara AM, Reeve BB, Scott JA, et al. ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage. 2010 Jun;39(6):1086–99.
Barsevick, Andrea M., et al. “ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials.J Pain Symptom Manage, vol. 39, no. 6, June 2010, pp. 1086–99. Pubmed, doi:10.1016/j.jpainsymman.2010.02.006.
Barsevick AM, Cleeland CS, Manning DC, O’Mara AM, Reeve BB, Scott JA, Sloan JA, ASCPRO (Assessing Symptoms of Cancer Using Patient-Reported Outcomes). ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage. 2010 Jun;39(6):1086–1099.
Journal cover image

Published In

J Pain Symptom Manage

DOI

EISSN

1873-6513

Publication Date

June 2010

Volume

39

Issue

6

Start / End Page

1086 / 1099

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Treatment Outcome
  • Terminology as Topic
  • Patients
  • Neoplasms
  • Humans
  • Fatigue
  • Clinical Trials as Topic
  • Anesthesiology